BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 16423884)

  • 21. Prurigo in dermatomyositis.
    Higuchi T; Satoh T; Yokozeki H
    Dermatology; 2008; 217(4):378-9. PubMed ID: 18827483
    [No Abstract]   [Full Text] [Related]  

  • 22. Extensive subcutaneous calcification: a rare manifestation of dermatomyositis.
    Huang W; Tang L
    Rheumatology (Oxford); 2019 Jun; 58(6):974. PubMed ID: 30534968
    [No Abstract]   [Full Text] [Related]  

  • 23. Calcinosis cutis associated with amyopathic dermatomyositis: response to intravenous immunoglobulin.
    Peñate Y; Guillermo N; Melwani P; Martel R; Hernández-Machín B; Borrego L
    J Am Acad Dermatol; 2009 Jun; 60(6):1076-7. PubMed ID: 19467386
    [No Abstract]   [Full Text] [Related]  

  • 24. Calcinosis cutis in juvenile dermatomyositis: remarkable response to aluminum hydroxide therapy.
    Wang WJ; Lo WL; Wong CK
    Arch Dermatol; 1988 Nov; 124(11):1721-2. PubMed ID: 3178257
    [No Abstract]   [Full Text] [Related]  

  • 25. Calcinosis cutis complicating adult-onset dermatomyositis.
    Weinel S; Callen JP
    Arch Dermatol; 2004 Mar; 140(3):365-6. PubMed ID: 15023788
    [No Abstract]   [Full Text] [Related]  

  • 26. Calcinosis universalis complicating juvenile dermatomyositis: resolution during probenecid therapy.
    Eddy MC; Leelawattana R; McAlister WH; Whyte MP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3536-42. PubMed ID: 9360503
    [No Abstract]   [Full Text] [Related]  

  • 27. Update on the treatment of calcinosis in dermatomyositis.
    Shinjo SK; Souza FH
    Rev Bras Reumatol; 2013 Apr; 53(2):211-4. PubMed ID: 23856799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapy of calcinosis universalis complicating adult dermatomyositis.
    Terroso G; Bernardes M; Aleixo A; Madureira P; Vieira R; Bernardo A; Costa L
    Acta Reumatol Port; 2013; 38(1):44-8. PubMed ID: 24131911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Calcinosis in dermatomyositis in children. Current therapeutic possibiltites].
    Nuyts JP; Bombart E; Deconinck B; Rey C; Gaudier B
    Pediatrie; 1973; 28(5):477-84. PubMed ID: 4766777
    [No Abstract]   [Full Text] [Related]  

  • 30. New insight into calcinosis of juvenile dermatomyositis: a study of composition and treatment.
    Mukamel M; Horev G; Mimouni M
    J Pediatr; 2001 May; 138(5):763-6. PubMed ID: 11343059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical features, treatments and outcomes of calcinosis in adult patients with dermatomyositis: a single cohort study.
    Jiang W; Yang H; Li S; Tian X; Wang G
    Rheumatology (Oxford); 2021 Jun; 60(6):2958-2962. PubMed ID: 33249499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement of calcinosis using pamidronate in a patient with juvenile dermatomyositis.
    Martillotti J; Moote D; Zemel L
    Pediatr Radiol; 2014 Jan; 44(1):115-8. PubMed ID: 23839717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subcutaneous immunoglobulin for the treatment of calcinosis associated with juvenile dermatomyositis.
    Rodríguez-Lozano AL; Mata-Aguilera X; Rivas-Larrauri F; Bustamante-Ogando JC; Gutierrez-Hernandez A; Bojalil-Cabildo A; Scheffler-Mendoza S; Yamazaki-Nakashimada M
    Int J Rheum Dis; 2024 Jun; 27(6):e15239. PubMed ID: 38923294
    [No Abstract]   [Full Text] [Related]  

  • 34. An extremely severe case of cutaneous calcinosis with juvenile dermatomyositis, and successful treatment with diltiazem.
    Ichiki Y; Akiyama T; Shimozawa N; Suzuki Y; Kondo N; Kitajima Y
    Br J Dermatol; 2001 Apr; 144(4):894-7. PubMed ID: 11298557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Case 104: calcinosis in juvenile dermatomyositis.
    Agarwal V; Sachdev A; Dabra AK
    Radiology; 2007 Jan; 242(1):307-11. PubMed ID: 17185675
    [No Abstract]   [Full Text] [Related]  

  • 36. Successful treatment of dermatomyositis and associated calcinosis with adalimumab.
    Xie F; Williams P; Batchelor R; Downs A; Haigh R
    Clin Exp Dermatol; 2020 Oct; 45(7):945-949. PubMed ID: 33448458
    [No Abstract]   [Full Text] [Related]  

  • 37. Colchicine suppression of local and systemic inflammation due to calcinosis universalis in chronic dermatomyositis.
    Taborn J; Bole GG; Thompson GR
    Ann Intern Med; 1978 Nov; 89(5 Pt 1):648-9. PubMed ID: 717938
    [No Abstract]   [Full Text] [Related]  

  • 38. Oral lesions as an initial manifestation of dermatomyositis with occult malignancy.
    Healy CM; Tobin AM; Kirby B; Flint SR
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Feb; 101(2):184-7. PubMed ID: 16448919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regression of calcinosis associated with adult dermatomyositis following diltiazem therapy.
    Vinen CS; Patel S; Bruckner FE
    Rheumatology (Oxford); 2000 Mar; 39(3):333-4. PubMed ID: 10788545
    [No Abstract]   [Full Text] [Related]  

  • 40. Bisphosphonate therapy for juvenile dermatomyositis-associated calcinosis and metaphyseal zebra lines.
    Janarthanan M; Mohan M; Murali A
    BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36343985
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.